Implied volatility isn’t just noise — it’s the heartbeat of the options market. In his latest YouTube video, Rick Orford ...

Nvidia Corporation recently announced a $100 billion investment in OpenAI, aiming to solidify a strategic partnership for ...

SDOF IV will continue UTI Alternatives’ disciplined approach to private credit, leveraging structures and active monitoring ...

In this Healio Video Perspective from Clinical Trials at the Summit, Michael A. Singer, MD, shares the results of a phase 2a trial investigating ANXV, a phosphatidylserine blocker designed to treat re ...

IV Solution and Ketamine Centers of Chicago continues to advance treatment options for post-traumatic stress disorder through ...

POET Technologies made progress in Malaysian production facilities, with a $500K order for optical engines. Check out a bull ...

FDA approves Keytruda Qlex, a subcutaneous injection version of the widely used cancer therapy Keytruda Patients can now ...

The FDA has approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya) for adults with moderately to severely ...

BioRestore Introduces Accessible IV Therapy to Enhance Patient Wellness Programs NEWTOWN, CT, UNITED STATES, September 15, 2025 /EINPresswire / -- BioRestore, a leading Connecticut-based medical ...

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...